Latest Biotech News

Nouscom secured an oversubscribed $135 million Series D to accelerate NOUS-209, its off-the-shelf neoantigen-based immunotherapy program in Lynch syndrome cancer interception. The FDA granted Fast...

Gilead Sciences reported Phase 2 results showing its oral inflammatory bowel disease candidate emvistegrast (2 00 mg daily) eliminated symptoms for patients with moderate-to-severe ulcerative...

Marengo Therapeutics said the FDA expanded fast track designation for invikafusp alfa (STAR0602) across pan-tumor TMB-H solid tumors that progressed after prior therapy, including checkpoint...

New findings highlighted a pair of blood signals that can diverge early and refine liver cancer therapy response assessment in hepatocellular carcinoma. The premise is that the first treatment...

A retrospective cohort study reported that the CAR-HEMATOTOX score predicts severe neutropenia and thrombocytopenia after CAR-T cell therapy, using data from 96 patients. The analysis described...

Liquidia shares rebounded after the company settled a long-running legal dispute with United Therapeutics, ending six lawsuits spanning patent infringement, trade secret, and antitrust claims....

A large international study found that performing stem cell transplants soon after high-risk bone marrow features emerge sharply improves survival for youth with Shwachman-Diamond syndrome. The...

Researchers reported a dual-pathway deep learning system that predicts tuberculosis drug resistance with over 95% accuracy while auditing sequencing quality and recovering both canonical and novel...

A new industry analysis focused on CDMO engagement timing argued that companies should involve contract development and manufacturing organizations early in development while keeping key CMC...

Saudi Arabia’s national biotechnology strategy has moved from a policy target toward operational partnerships, according to reporting on agreements announced at the Riyadh Global Medical...

Marengo Therapeutics’ bispecific immuno-oncology agent invikafusp alfa (STAR0602) won an expanded FDA fast track designation across TMB-H solid tumors after prior therapy, including patients...

Liquidia’s patent settlement with United Therapeutics resolved six lawsuits tied to treprostinil inhalation, with Liquidia agreeing to pay $380.7 million and to remove pulmonary hypertension...

OMass secured $310 million to advance a drug program for congenital adrenal hyperplasia, targeting an option intended to compete in a market dominated by Neurocrine’s current FDA-approved therapy....

A sequence of imaging AI studies reported new approaches to predict tumor features without invasive sampling, including a model that reads routine CT urography to predict bladder cancer HER2...

Single-cell sequencing work mapped distinct T-cell exhaustion programs that emerge in acute myeloid leukemia before and after transplant, linking relapse biology to different transcriptional...

A Mount Sinai study reported that BCMA-directed CAR-T cells can linger in the gut and correlate with severe intestinal inflammation in a subset of patients. The finding ties therapy persistence in...

The phase 3 RxFINE-Low trial will test whether some early-stage breast cancer patients can safely omit chemotherapy when they have low genomic risk but high anatomic risk. Enrolled patients will...

Caravel Bio advanced a microfluidic platform for protein engineering that couples cell-free synthesis in microdroplets with a bacterial spore-based display concept. The approach targets industrial...

Researchers developed ebastine-loaded Solusome nanovesicle oral lyophilisates designed to disintegrate quickly in the mouth and boost systemic exposure. In rats, the formulation increased ebastine...

Thailand-based researchers reported that a cheap Tris–EDTA buffer DNA extraction method can match commercial extraction kits when paired with RPA and CRISPR–Cas12a for rapid detection of Babesia...